30
Jun
EverHint – Cap Large Only – Top 10 Signals for Jun 30, 2026
10 signals. Technology leads (5). price range $72-$723. 4 with insider selling.
4 min read
Latest
30
Jun
EverHint – Sector Tech – Top 11 Signals for Jun 30, 2026
11 signals. Technology leads (11). price range $25-$723. 3 with insider selling.
4 min read
30
Jun
EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Jun 30, 2026
20 signals (from 53 total). Technology leads (13). price range $4-$397. 2 with insider buying. 9 with insider selling.
3 min read
30
Jun
EverHint – Dip Bounce V2 (Reclaim) – Top 15 Signals for Jun 30, 2026
15 signals (from 56 total). Technology leads (23). price range $5-$763. 5 with insider selling.
3 min read
30
Jun
EverHint – Breakout Ultra Tight – Top 12 Signals for Jun 30, 2026
12 signals. Technology leads (5). price range $19-$378. 4 with insider selling.
3 min read
30
Jun
EverHint – Breakout Standard – Top 15 Signals for Jun 30, 2026
15 signals (from 27 total). Technology leads (11). price range $19-$723. 9 with insider selling.
3 min read
30
Jun
EverHint – Aggressive Momentum – Top 5 Signals for Jun 30, 2026
5 signals. Technology leads (2). price range $37-$333. 3 with insider selling.
3 min read
30
Jun
Stock Market News — June 30, 2026 — Morning Update — Last 12 Hours (Pacific Time)
Semiconductor stocks surge to record market share as the Philadelphia chip index posts its best first-half performance since the dotcom era, up ~94%, while NVIDIA and AMD recover on bullish outlooks. A landmark Visa/Mastercard stablecoin launch reshapes crypto payments, though BMW's profit margin co
9 min read
29
Jun
EverHint Layoff News Digest — June 29, 2026
Summary
🔴 Cisco to lay off more than 400 workers in California
🟡 ❗️Nationwide to cut 600 jobs in first redundancies after
29
Jun
Stock Market News — June 29, 2026 — Evening Update — Last 12 Hours (Pacific Time)
Nasdaq surged 2% and the Dow hit a record close Monday, powered by Alphabet's historic debut in the Dow and broad tech strength. After-hours saw biotech wins (Gain Therapeutics +21%, Abivax +18.5%) offset by a telecom rout and Uber-Waymo's robotaxi breakup.
7 min read